MELODY MOORE: Open Payments
NPI 1447287552 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 22 payments from 9 companies in 2025. Trend: 2023 $420 · 2024 $691 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $144 |
| ABBVIE INC. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Amgen Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: Wegovy, UBRELVY, Ozempic, REXULTI, SPRAVATO, FREESTYLE LIBRE 3, QULIPTA, SHINGRIX.
Industry payments across NC — which companies pay providers there.
